SUBCUTANEOUS PANNICULITIS-LIKE T-CELL LYMPHOMA
Clinical trials for SUBCUTANEOUS PANNICULITIS-LIKE T-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new SUBCUTANEOUS PANNICULITIS-LIKE T-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for SUBCUTANEOUS PANNICULITIS-LIKE T-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Vitamin d boost may extend life in lymphoma patients, trial hopes
Disease control OngoingThis study looks at whether giving vitamin D supplements to people with newly diagnosed lymphoma or chronic lymphocytic leukemia who have low vitamin D levels can improve their survival and delay the need for treatment. About 565 participants are being given vitamin D3 or a place…
Matched conditions: SUBCUTANEOUS PANNICULITIS-LIKE T-CELL LYMPHOMA
Phase: NA • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New combo shows promise for rare blood cancer
Disease control OngoingThis early-stage study tested a combination of two drugs (pembrolizumab and pralatrexate) in 13 people with peripheral T-cell lymphoma that had returned or not responded to prior treatment. The goal was to find the safest dose and see if the combo could shrink tumors. The approac…
Matched conditions: SUBCUTANEOUS PANNICULITIS-LIKE T-CELL LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC